Adar1 Capital Management, LLC Dyne Therapeutics, Inc. Transaction History
Adar1 Capital Management, LLC
- $500 Billion
- Q4 2024
Shares
2 transactions
Others Institutions Holding DYN
# of Institutions
213Shares Held
103MCall Options Held
135KPut Options Held
435K-
Atlas Venture Life Science Advisors, LLC8.02MShares$97.7 Million31.16% of portfolio
-
Black Rock Inc. New York, NY7.39MShares$90 Million0.01% of portfolio
-
Janus Henderson Group PLC London, X07.38MShares$89.9 Million0.09% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.7MShares$81.7 Million0.0% of portfolio
-
Ra Capital Management, L.P. Boston, MA6.38MShares$77.7 Million2.43% of portfolio
About Dyne Therapeutics, Inc.
- Ticker DYN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 51,765,400
- Market Cap $631M
- Description
- Dyne Therapeutics, Inc., a muscle disease company, operates as a biotechnology company that focuses on advancing therapeutics for genetically driven muscle diseases in the United States. It develops various programs for myotonic dystrophy type 1, duchenne muscular dystrophy, and facioscapulohumeral dystrophy, as well as rare skeletal muscle, and...